Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

28 in total

1. Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.

Authors: Ji Hyun Kwon; Young-Il Koh; Sung-Soo Yoon; Seonyang Park; Inho Kim
Journal: Int J Hematol Date: 2016-07-18 Impact factor: 2.490

2. Frequency of complete remission after standard 3+7 induction therapy in patients with acute myeloid leukemia.

Authors: Iram Shireen; Sumra Komal; Abida Mateen Ansari; Lubna Meraj
Journal: Pak J Med Sci Date: 2022 May-Jun Impact factor: 2.340

3. Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia.

Authors: Adrian Krygier; Dagmara Szmajda; Marta Żebrowska; Agnieszka Jeleń; Ewa Balcerczak
Journal: Oncol Lett Date: 2018-03-01 Impact factor: 2.967

Review 4. Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia.

Authors: Lesley J Scott
Journal: Drugs Date: 2016-05 Impact factor: 9.546

5. Fludarabine, High Dose Cytarabine and Granulocyte Colony-Stimulating Factor (FLAG) as Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study.

Authors: Kian Boon Law; Kian Meng Chang; Nor Aishah Hamzah; Kok Haur Ng; Tee Chuan Ong
Journal: Indian J Hematol Blood Transfus Date: 2017-02-14 Impact factor: 0.900

Review 6. Evaluating measurable residual disease in acute myeloid leukemia.

Authors: Farhad Ravandi; Roland B Walter; Sylvie D Freeman
Journal: Blood Adv Date: 2018-06-12

Review 7. Polo-like kinases and acute leukemia.

Authors: Oksana Goroshchuk; Iryna Kolosenko; Linda Vidarsdottir; Alireza Azimi; Caroline Palm-Apergi
Journal: Oncogene Date: 2018-08-13 Impact factor: 9.867

8. The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy.

Authors: Yi Chen; Ting Yang; Xiaoyun Zheng; Xiaozhu Yang; Zhihong Zheng; Jing Zheng; Tingbo Liu; Jianda Hu
Journal: Medicine (Baltimore) Date: 2016-07 Impact factor: 1.889

9. Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications.

Authors: Sabyasachi Chakrabortty; Bikram Keshari Agrawalla; Anne Stumper; Naidu M Vegi; Stephan Fischer; Christian Reichardt; Michael Kögler; Benjamin Dietzek; Michaela Feuring-Buske; Christian Buske; Sven Rau; Tanja Weil
Journal: J Am Chem Soc Date: 2017-02-07 Impact factor: 15.419

10. Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemia.

Authors: Sonya Cressman; Aly Karsan; Donna E Hogge; Emily McPherson; Corneliu Bolbocean; Dean A Regier; Stuart J Peacock
Journal: Br J Haematol Date: 2016-04-21 Impact factor: 6.998